SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

390

Participants

Timeline

Start Date

November 26, 2012

Primary Completion Date

September 20, 2013

Study Completion Date

September 20, 2013

Conditions
Binge Eating Disorder
Interventions
DRUG

SPD489 (Lisdexamfetamine dimesylate)

50 or 70 mg administered orally, once-daily for up to 12 weeks

DRUG

Placebo

Administered once-daily, orally, for up to 12 weeks

Trial Locations (48)

10023

CNS Clinica at the Brain Resource Center, New York

10117

Klinische Forschung Berlin-Mitte GmbH, Berlin

10549

Bioscience Research, LLC, Mount Kisco

13125

Klinische Forschung Berlin Buch GmbH, Berlin

18104

Lehigh Center for Clinical Research, Allentown

19055

Klinische Forschung Schwerin GmbH, Schwerin

19139

CRI Lifetree, Philadelphia

20170

NeuroScience, Inc., Herndon

20877

Potomac Grove Clinical Research Center, Gaithersburg

29650

Radiant Research, Inc., Greer

30342

NeuroTrials Research, Inc., Atlanta

32751

Florida Clinical Research Center, LLC, Maitland

32806

Clinical Neuroscience Solutions, Inc., Orlando

33143

Miami Research Associates, South Miami

34201

Florida Clinical Research Center, LLC, Bradenton

37203

Clinical Research Associates, Inc., Nashville

44311

Radiant Research, Inc., Akron

45040

The Craig and Frances Lindner Center of Hope, Mason

45215

Patient Priority Clinical Sites, LLC, Cincinnati

47630

Deaconess Clinic Gateway Health Center, Newburgh

48307

Rochester Center for Behavioral Medicine, Rochester Hills

55454

UMN Medical School, Dept of Psychiatry, Minneapolis

60048

Capstone Clinical Research, Libertyville

60523

American Medical Research, Oak Brook

63141

Scientella, LLA, St Louis

66206

Clinical Trials Technology, Inc., Prairie Village

70114

Louisiana Research Associates, Inc., New Orleans

75093

Psychiatric Medical Associates, Plano

77081

Texas Center for Drug Development, Inc., Houston

78229

Radiant Research, Inc., San Antonio

80239

Radiant Research, Inc., Denver

84405

Advanced Research Institute, Ogden

85710

Radiant Research, Inc., Tucson

89102

Robert Lynn Horne, MD, LTD, Las Vegas

90210

Southern California Research, LLC, Beverly Hills

92037

Scripps Clinical Research Services, La Jolla

92056

Excel Research, Inc., Oceanside

92108

PCSD - Feighner Research, San Diego

92660

Pharmacology Research Institute, Newport Beach

97210

Oregon Center for Clinical Investigators (OCCI, Inc), Portland

97401

Clinical Trials of America, Inc., Eugene

97504

Sunstone Medical Research, LLC, Medford

98104

Summit Research Network (Seattle), LLC, Seattle

02131

Boston Clinical Trials, Boston

01830

Activmed Practices and Research, Haverhill

02472

Adams Clinical Trials, LLC, Watertown

08540

Global Medical Inst LLC; Princeton Medical Institute, Princeton

02886

Omega Medical Reserach, Warwick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY

NCT01718509 - SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder | Biotech Hunter | Biotech Hunter